NCT05043324View on ClinicalTrials.gov

Prevention and Treatment of Patient Before, During, and After Covid-19 Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

February 20, 2020

Primary Completion Date

April 20, 2022

Study Completion Date

April 27, 2022

Conditions
Covid19
Interventions
DRUG

AntiCov-220

The daily maintenance, AntiCov-220 dose is to take 3 times a day, 1 tablet each time.

DRUG

AntiCov-220 (placebo)

The daily maintenance, AntiCov-220 (placebo) dose is to take 3 times a day, 1 tablet each time.

Trial Locations (2)

700000

Saigon Biopharma Company Limited, Ho Chi Minh City

19801-6601

Saigon Biopharma LLC, Wilmington

All Listed Sponsors
lead

Nguyen Thi Trieu, MD

INDIV

NCT05043324 - Prevention and Treatment of Patient Before, During, and After Covid-19 Infection | Biotech Hunter | Biotech Hunter